title: A secreted serine protease can induce apoptosis in Pam212 keratinocytes.
abstract: The epidermal keratinocyte cell line Pam212 undergoes spontaneous apoptosis in culture, providing an in vitro model for the early steps of epidermal differentiation. Pam212 cells exhibit characteristics of basal keratinocytes, committed for the transition to the spinous layer of the epidermis. Bcl-2 can regulate the differentiation of these cells by negatively regulating several genes that have been implicated in apoptosis. We show evidence that a serine protease activity, secreted by the Pam212 cells, could induce apoptosis in Pam212 and several other cell lines. This activity might be regulated via the bcl-2 pathway. We suggest that this serine protease could either directly, via binding and/or cleavage of a serine protease-activated receptor, or indirectly, via the cleavage of an unknown protein, activate the signaling for apoptosis in Pam212 cells. Alternatively, this secreted serine protease could reenter the cell and start a proteolytic cascade reaction that leads to cell death. This is based on the induction of apoptosis in several cell lines by the partially purified serine protease activity, and the minimal effect of protein synthesis inhibition on Pam212 apoptosis. We propose that in vivo, a two-step mechanism controls keratinocyte apoptosis and differentiation. The basal cells of the epidermis contain all of the necessary proteins required for apoptosis, as well as the repressor protein Bcl-2. As Bcl-2 levels go down, the cells commit to terminal differentiation. A serine protease, secreted from these cells, then induces the death process. This second step enables the cells to undergo apoptosis and continue the process of terminal differentiation.
authors.affiliation: Skin Biology Research Center, R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869, USA.
authors.forename: J
authors.initials: J
authors.lastname: Marthinuss
authors.forename: P
authors.initials: P
authors.lastname: Andrade-Gordon
authors.forename: M
authors.initials: M
authors.lastname: Seiberg
mesh_terms: D016475:3T3 Cells / Q000502:physiology; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D001483:Base Sequence; D001943:Breast Neoplasms; D006528:Carcinoma, Hepatocellular; D002461:Cell Line, Transformed; D017077:Culture Media, Conditioned; D004249:DNA Damage / Q000502:physiology; D006801:Humans; D015603:Keratinocytes / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D011505:Protein-Tyrosine Kinases / Q000502:physiology; D011518:Proto-Oncogene Proteins / Q000502:physiology; D019253:Proto-Oncogene Proteins c-bcl-2; D012697:Serine Endopeptidases / Q000302:isolation & purification / Q000378:metabolism / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D013025:Glycine max; D014357:Trypsin / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000502:physiology
chemical_list: D017077:Culture Media, Conditioned; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D014361:Trypsin Inhibitors; D011505:Protein-Tyrosine Kinases; D012697:Serine Endopeptidases; D014357:Trypsin